Telum Therapeutics
Announced 19 Oct 2026$20.1M ยท Series A ยท Manufacturing ยท Spain
Telum Therapeutics SL is a global leader in drug discovery, leveraging Synthetic Biology and AI-driven Machine Learning to develop cutting-edge antimicrobial solutions.
โ๐ Vestor Club: Spain's biotech pioneer is tackling antimicrobial resistance with precision therapies! ๐ช๐ธ ๐ค Telum Therapeutics secures an โฌ18M Series A round led by the AMR Action Fund to advance its novel antimicrobial therapies through Phase 1 clinical trials.โ
10 more sources tracked. Read the full press release and reporter coverage.
Sign up to read โInvestors: AMR Action Fund.